– CANADA, Montréal – Anasens, a company with innovative technology enabling the rapid quantification of biomarkers in any environment requiring immediate response, announced the appointment of Pierre Fitzgibbon to its Board of Directors.
About Pierre Fitzgibbon
Pierre Fitzgibbon, former Quebec Minister of Economy, Innovation, and Energy and an experienced businessman, brings extensive expertise in corporate governance and technological innovation. Over his remarkable career, Pierre has held leadership roles in politics, finance, and business. He was first elected as a Member of the National Assembly for Terrebonne with the Coalition Avenir Québec in 2018 and re-elected in 2022. He recently served as Minister of Economy, Innovation, and Energy until September 2024. Since leaving politics, Pierre Fitzgibbon has joined Osler, Hoskin & Harcourt LLP, one of Canada’s leading business law firms, as a special advisor. Concordia University’s Volt-Age program recently appointed the former Quebec Minister of Economy, Innovation, and Energy to its advisory committee.
Previously, Pierre Fitzgibbon was Managing Partner at Walter Capital Partners, a private equity firm, from 2015 to 2018. From 2007 to 2014, he served as President and CEO of Atrium Innovations, a company founded by Mr. Dupont and his brother Luc, specializing in the development, manufacturing, and marketing of products for the health and nutrition industry.
Recognized for his strong business acumen, Pierre Fitzgibbon has served on the boards of public and private companies, including the Caisse de dépôt et placement du Québec, WSP, Héroux-Devtek, Transcontinental Group, Cycle Capital Management, Neptune Technologies, Lumenpulse, and Arianne Phosphate. He is distinguished by his ability to transform businesses and build strategic partnerships, solidifying his reputation as one of the most influential economic leaders of his generation.
“I am truly pleased to once again collaborate with Eric Dupont and the other members of Anasens’ Board and management team to support their business development efforts both domestically and internationally,” said Pierre Fitzgibbon.
About Anasens
Anasens is a deep tech company developing an innovative platform for rapid, quantitative, and connected detection, enabling the analysis of various biological matrices at home, bedside, or elsewhere. This cutting-edge technology, developed in the laboratory of Prof. Alexis Vallée-Bélisle, Canada Research Chair in Bioengineering and Bio-nanotechnology, has been under development at the Université de Montréal for over 10 years. The first product in its portfolio, DrugAsens, is the inaugural offering in a series of innovative tests designed to detect drugs of abuse within minutes directly from saliva. Affordable, easy to use, rapid, sensitive, and specific, it far surpasses the technologies currently available on the market.
For more information: https://anasens.com/en/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.